Cognitive Appraisals and Team Performance Under Stress in Simulated Trauma Care

Sponsor
Azienda Usl di Bologna (Other)
Overall Status
Recruiting
CT.gov ID
NCT05083871
Collaborator
Manchester Metropolitan University (Other), Humanitas Clinical and Research Center (Other), Azienda Sanitaria Universitaria Friuli Centrale (Other)
130
1
29.3
4.4

Study Details

Study Description

Brief Summary

Medical teams work in demanding situations that are often uncertain, changeable and require accurate decision-making, skilled movement and coordinated action. How teams perform matters for patient outcomes. In addition to medical expertise, how individuals and the team collectively respond and manage the psychological stress of the situation has a significant impact on performance. One approach, which attempts to explain the facilitating and debilitating effects of stress on performance is the biopsychosocial model of challenge and threat. A challenge state occurs when perceived personal resources meet or exceed the situation's demands, whereas threat occurs when demands exceed resources. Challenge states have been consistently associated with improved performance in a range of environments and activities, including medical settings. In a recent study conducted during a national simulation-based training event for residents (the SIMCUP Italia 2018) it was found that a high level of resources is associated with better performance until demands become very high. The present study builds on previous work to explore how challenge and threat states are linked to performance. It includes a more recently developed and robust measure of demands and resource appraisals. In addition, secondary aims include the exploration of how psychological variables, specifically cognitive anxiety, somatic anxiety, self-confidence and social identity (connection with other members of the medical team) are linked to challenge and threat and performance. Understanding the psychological determinants of performance in critical care can provide the basis for individual and team-based interventions to improve critical care team performance.

Condition or Disease Intervention/Treatment Phase
  • Other: European Trauma Course

Study Design

Study Type:
Observational
Anticipated Enrollment :
130 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Cognitive Appraisals and Team Performance Under Stress in Simulated Trauma Care
Actual Study Start Date :
Oct 20, 2021
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Mar 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Learners of the European Trauma Course

Learners attending the European Trauma Course

Other: European Trauma Course
Structured learning program specifically focused on Trauma management. The course provides frontal lessons, workshops for the technical skills and simulated scenarios. Please see https://www.erc.edu/courses/european-trauma-course for additional details

Outcome Measures

Primary Outcome Measures

  1. Performance in simulated emergency trauma care [3 days]

    Composite outcome measure taking into account both technical and non technical skills evaluation from the course instructors

Secondary Outcome Measures

  1. participants' perceptions of task demands vs. personal resources [3 days]

    Evaluation of the evolution of the participants' perceptions of task demands vs. personal resources throughout the course

  2. mental readiness [3 days]

    Evaluation of the evolution of the participants' mental readiness throughout the course

  3. Social identity [3 days]

    Evaluation of the evolution of the participants' social identity throughout the course

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Learners of the European Trauma Course in Italy
Exclusion Criteria:
  • Age < 18 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Azienda Unità Sanitaria Locale Bologna Italy 40100

Sponsors and Collaborators

  • Azienda Usl di Bologna
  • Manchester Metropolitan University
  • Humanitas Clinical and Research Center
  • Azienda Sanitaria Universitaria Friuli Centrale

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Azienda Usl di Bologna
ClinicalTrials.gov Identifier:
NCT05083871
Other Study ID Numbers:
  • 798-2021-OSS-AUSLBO
First Posted:
Oct 19, 2021
Last Update Posted:
Feb 16, 2022
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Azienda Usl di Bologna
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 16, 2022